Alembic Pharmaceuticals Ltd

NSE: APLLTD BSE: 533573

₹677.30

(3.33%)

Tue, 31 Mar 2026, 07:49 am

MTF 5xInvest in Alembic Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap133.08B

PE Ratio21.17

Dividend1.62

Health Technology

Pharmaceuticals: Major

24.5K

Alembic Pharmaceuticals Income Statement

Income Statement Balance Sheet Cashflow

Particulars	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total revenue	11.38B	11.84B	14.38B	14.94B	18.24B	20.18B	30.66B	30.52B	30.60B	38.46B	45.06B	52.83B	52.67B	55.71B	61.23B	65.51B
Gross profit	752.10M	3.63B	4.49B	5.12B	7.26B	8.50B	17.16B	16.11B	15.22B	16.34B	19.32B	23.62B	19.62B	19.04B	21.63B	23.19B
Operating expenses (excl. COGS)	-56.50M	-2.50B	-2.84B	-3.24B	-4.44B	-5.35B	-8.34B	-11.22B	-10.69B	-9.66B	-9.07B	-11.55B	-13.90B	-15.16B	-15.87B	-16.94B
Selling/general/admin expenses, total	—	-2.39B	-2.74B	-3.18B	-4.29B	-5.20B	-8.27B	-11.13B	-10.63B	-9.56B	-8.94B	-11.41B	-13.75B	-14.99B	-15.69B	-16.76B
Research & development	—	-471.32M	-585.82M	-736.33M	-1.16B	-1.22B	-3.07B	-4.13B	-3.91B	-4.68B	-5.82B	-6.26B	-6.73B	-6.22B	-4.39B	-4.86B
Selling/general/admin expenses, other	—	-1.91B	-2.15B	-2.44B	-3.12B	-3.98B	-5.20B	-7.00B	-6.73B	-4.88B	-3.13B	-5.15B	-7.02B	-8.77B	-11.30B	-11.90B
Other operating expenses, total	-56.50M	-109.90M	-98.12M	-59.84M	-152.33M	-152.77M	-73.80M	-88.60M	-58.20M	-102.30M	-126.00M	-139.70M	-151.30M	-166.90M	-181.50M	-179.50M
Operating income	695.60M	1.14B	1.65B	1.88B	2.82B	3.15B	8.82B	4.89B	4.53B	6.68B	10.25B	12.07B	5.72B	3.88B	5.76B	6.26B
Non-operating income, total	-257.50M	-66.71M	-37.02M	185.28M	284.87M	440.79M	545.10M	400.20M	880.00M	817.50M	-251.00M	1.61B	483.90M	-28.80M	570.00M	807.40M
Interest expense, net of interest capitalized	-300.50M	-238.89M	-375.48M	-239.82M	-104.00M	-38.08M	-54.30M	-52.30M	-34.00M	-184.10M	-271.60M	-160.20M	-177.30M	-501.70M	-561.90M	-787.70M
Interest capitalized	—	0	0	0	0	0	0	23.70M	226.10M	0	832.10M	0	0	0	0	0
Non-operating income, excl. interest expenses	43.00M	164.30M	328.66M	388.05M	367.27M	474.21M	550.10M	440.40M	905.80M	984.80M	983.20M	1.75B	652.40M	457.70M	1.08B	1.46B
Non-operating interest income	—	—	113.35M	94.08M	5.91M	20.27M	17.50M	10.30M	6.20M	25.80M	17.30M	15.80M	17.30M	3.30M	20.90M	59.60M
Miscellaneous non-operating expense	43.00M	164.30M	215.31M	293.98M	361.36M	453.94M	532.60M	430.10M	899.60M	959.00M	965.90M	1.73B	635.10M	454.40M	1.06B	1.40B
Unusual income/expense	—	7.88M	9.80M	37.05M	21.60M	4.66M	49.30M	12.10M	8.20M	16.80M	-962.60M	18.90M	8.80M	15.20M	47.40M	137.70M
Pretax income	438.10M	1.07B	1.61B	2.06B	3.11B	3.59B	9.36B	5.29B	5.41B	7.49B	10.00B	13.68B	6.20B	3.86B	6.33B	7.06B
Taxes	-42.70M	-214.50M	-308.50M	-411.00M	-751.03M	-763.49M	-2.16B	-1.22B	-1.20B	-1.57B	-1.99B	-2.53B	-1.04B	-126.00M	-160.10M	-1.25B
Non-controlling/minority interest	0	0	0	0	0	0	0	900.00K	-1.90M	10.80M	281.20M	0	0	0	0	14.10M
After tax other income/expense	—	—	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	395.40M	853.88M	1.30B	1.65B	2.36B	2.83B	7.20B	4.03B	4.13B	5.84B	8.29B	11.46B	5.21B	3.42B	6.16B	5.83B
Net income	395.40M	853.88M	1.30B	1.65B	2.36B	2.83B	7.20B	4.03B	4.13B	5.84B	8.29B	11.46B	5.21B	3.42B	6.16B	5.83B
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	395.40M	853.88M	1.30B	1.65B	2.36B	2.83B	7.20B	4.03B	4.13B	5.84B	8.29B	11.46B	5.21B	3.42B	6.16B	5.83B
Basic earnings per share (Basic EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted earnings per share (Diluted EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	1.13B	1.43B	1.98B	2.23B	3.23B	3.59B	9.54B	5.72B	5.59B	7.83B	11.82B	13.91B	8.59B	6.64B	8.48B	9.04B
EBIT	695.60M	1.14B	1.65B	1.88B	2.82B	3.15B	8.82B	4.89B	4.53B	6.68B	10.25B	12.07B	5.72B	3.88B	5.76B	6.26B
Total operating expenses	-10.69B	-10.70B	-12.73B	-13.06B	-15.42B	-17.03B	-21.84B	-25.63B	-26.07B	-31.79B	-34.81B	-40.76B	-46.96B	-51.83B	-55.47B	-59.25B
Prepaid expenses	—	—	3.54M	8.69M	1.55B	2.24B	70.80M	75.50M	153.20M	182.40M	281.00M	357.30M	370.70M	553.20M	500.50M	691.80M
Deferred income, current	—	—	—	—	—	—	—	13.50M	94.70M	36.20M	64.90M	235.20M	692.20M	396.20M	157.60M	174.60M
Capital and operating lease obligations	—	0	0	0	0	0	0	0	0	0	733.00M	721.40M	692.30M	692.30M	628.80M	467.70M
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	—	53.75M	290.15M	304.56M	390.37M	476.81M	665.50M	922.20M	1.19B	1.41B	1.60B	1.89B	1.98B	831.40M	1.31B	1.39B
Deferred income, non-current	—	—	—	—	—	—	0	0	0	—	—	—	—	—	—	—
Minority interest	0	0	0	0	0	0	0	1.10M	3.10M	-7.90M	-289.60M	0	0	0	0	-14.20M
Change in accrued expenses	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	—	0	-216.45M	-303.62M	-545.78M	-654.96M	-787.00M	-901.00M	-907.60M	-909.10M	-3.26B	0	-2.75B	-1.97B	-1.57B	-2.16B
Preferred dividends paid	—	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800